Skip to content

Study · Not a test of the peptide alone · 2024

3 results

[Evaluation of the effectiveness of the drug Cortexin in combination with the use of the application Aphasia.No (Afaziyam.Net) in the correction of speech disorders in patients with cerebral infarction].

Kuznetsova EB, Selivanova JV, Gerber AV

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova1 Jan 2024Cited by 1 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study3

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone3

In this study, Cortexin (cortical polypeptide complex) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Cortexin (cortical polypeptide complex).

  1. 01HumanNot a test of Cortexin (cortical polypeptide complex) aloneNon-randomized trialEfficacy outcome

    In stroke patients with aphasia, Cortexin plus app-based rehabilitation improved speech scores significantly from baseline and versus the comparison group.

    In plain wordsStroke patients who received Cortexin plus app-based rehabilitation had better speech scores than at baseline and in the comparison group.

    Outcome
    IncreaseSpeech score
    Study

    n = 71

    Comparator
    Comparison group and pretreatment baseline
    Outcome group
    Cognition and memory · Nervous system and cognition

    Measurements

    Speech score
    141.8 points
    day 2 in hospital (baseline)
    Speech score
    214.3 points
    before discharge

    Source sentences

    Summary
    An examination before discharge in IG showed the following results: speech - 214.3±15.9; writing - 31.5±4.5; reading - 24.4±4.7 points.
    Summary
    The average score based on the results of a comprehensive study of speech, writing and reading in the group on day 2 in the hospital was: speech - 141.8±21.6 (normal - 262 points); writing - 20.5±4.23 (normal - 44 points); reading - 14.5±1.87 (normal - 29 points) points.
    2 context sentences
    Summary · context
    The differences compared to the baseline and the 2nd group were statistically significant.
    Summary · context
    50 of them consented to neuropsychological rehabilitation using the application Aphasia.No (Afaziyam.Net) and received the drug Cortexin as a peptide drug at a dose of 10 mg 2 times a day intramuscularly (IG).

    In this study, Cortexin (cortical polypeptide complex) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cortexin (cortical polypeptide complex).

  2. 02HumanNot a test of Cortexin (cortical polypeptide complex) aloneNon-randomized trialEfficacy outcome

    In stroke patients with aphasia, Cortexin plus app-based rehabilitation improved writing scores significantly from baseline and versus the comparison group.

    In plain wordsStroke patients who received Cortexin plus app-based rehabilitation had better writing scores than at baseline and in the comparison group.

    Outcome
    IncreaseWriting score
    Study

    n = 71

    Comparator
    Comparison group and pretreatment baseline
    Outcome group
    Cognition and memory · Nervous system and cognition

    Measurements

    Writing score
    20.5 points
    day 2 in hospital (baseline)
    Writing score
    31.5 points
    before discharge

    Source sentences

    Summary
    An examination before discharge in IG showed the following results: speech - 214.3±15.9; writing - 31.5±4.5; reading - 24.4±4.7 points.
    Summary
    The average score based on the results of a comprehensive study of speech, writing and reading in the group on day 2 in the hospital was: speech - 141.8±21.6 (normal - 262 points); writing - 20.5±4.23 (normal - 44 points); reading - 14.5±1.87 (normal - 29 points) points.
    2 context sentences
    Summary · context
    The differences compared to the baseline and the 2nd group were statistically significant.
    Summary · context
    50 of them consented to neuropsychological rehabilitation using the application Aphasia.No (Afaziyam.Net) and received the drug Cortexin as a peptide drug at a dose of 10 mg 2 times a day intramuscularly (IG).

    In this study, Cortexin (cortical polypeptide complex) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cortexin (cortical polypeptide complex).

  3. 03HumanNot a test of Cortexin (cortical polypeptide complex) aloneNon-randomized trialEfficacy outcome

    In stroke patients with aphasia, Cortexin plus app-based rehabilitation improved reading scores significantly from baseline and versus the comparison group.

    In plain wordsStroke patients who received Cortexin plus app-based rehabilitation had better reading scores than at baseline and in the comparison group.

    Outcome
    IncreaseReading score
    Study

    n = 71

    Comparator
    Comparison group and pretreatment baseline
    Outcome group
    Cognition and memory · Nervous system and cognition

    Measurements

    Reading score
    14.5 points
    day 2 in hospital (baseline)
    Reading score
    24.4 points
    before discharge

    Source sentences

    Summary
    An examination before discharge in IG showed the following results: speech - 214.3±15.9; writing - 31.5±4.5; reading - 24.4±4.7 points.
    Summary
    The average score based on the results of a comprehensive study of speech, writing and reading in the group on day 2 in the hospital was: speech - 141.8±21.6 (normal - 262 points); writing - 20.5±4.23 (normal - 44 points); reading - 14.5±1.87 (normal - 29 points) points.
    2 context sentences
    Summary · context
    The differences compared to the baseline and the 2nd group were statistically significant.
    Summary · context
    50 of them consented to neuropsychological rehabilitation using the application Aphasia.No (Afaziyam.Net) and received the drug Cortexin as a peptide drug at a dose of 10 mg 2 times a day intramuscularly (IG).

    In this study, Cortexin (cortical polypeptide complex) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Cortexin (cortical polypeptide complex).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    22 Oct 2026, 02:25 UTC

    Study results updated

  2. Version 1

    21 Oct 2026, 18:59 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.